CN207636495U - A kind of serum amyloid A protein assay kit - Google Patents
A kind of serum amyloid A protein assay kit Download PDFInfo
- Publication number
- CN207636495U CN207636495U CN201721918920.7U CN201721918920U CN207636495U CN 207636495 U CN207636495 U CN 207636495U CN 201721918920 U CN201721918920 U CN 201721918920U CN 207636495 U CN207636495 U CN 207636495U
- Authority
- CN
- China
- Prior art keywords
- reagent bottle
- reagent
- bottle
- connection sheet
- serum amyloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000054727 Serum Amyloid A Human genes 0.000 title claims abstract description 28
- 101710190759 Serum amyloid A protein Proteins 0.000 title claims abstract description 26
- 238000002731 protein assay Methods 0.000 title claims abstract description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 169
- 230000007423 decrease Effects 0.000 claims abstract description 10
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 claims description 13
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 abstract description 3
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108700028909 Serum Amyloid A Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
- 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
- 101710153593 Albumin A Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000010010 raising Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model is related to reagent bottle fields, more particularly to a kind of serum amyloid A protein assay kit, including the first reagent bottle, the second reagent bottle and third reagent bottle being set up in parallel, connector is equipped between first reagent bottle, the second reagent bottle and third reagent bottle, the capacity of first reagent bottle, the second reagent bottle and third reagent bottle successively decreases successively, and the bottleneck bore of the first reagent bottle, the second reagent bottle and third reagent bottle successively decreases successively.The amount of capacity of first reagent bottle of the utility model, the second reagent bottle and third reagent bottle is successively decreased successively, the ratio between capacity measures required ratio of reagents to design according to serum amyloid A protein, after repeatedly measuring, first reagent bottle, the second reagent bottle and third reagent bottle sky can fall together, therefore, also can be very convenient in buying and the preservation of reagent, record, and according to amount of capacity, the bottleneck for devising different bores avoids once pouring out excessive.
Description
Technical field
The utility model is related to reagent bottle field, more particularly to a kind of serum amyloid A protein assay kit.
Background technology
Serum amyloid A protein (SAA) is the serum precursor of main constituents amyloid A protein in amyloidosis, is
A kind of acute phase protein being secreted into after being generated by liver cell in serum, although being seen everywhere, under normal circumstances,
Express in human body still very low, however body is once being inflamed, infect or when tissue damage, SAA levels can be in 5~6h
Rapid to increase about 1000 times, studies have shown that is in bacterium, fungi, viral infection, atherosclerosis, angiocardiopathy, acute shifting
It plants and can detect SAA raisings in blood in the diseases such as rejection, decline rapidly in the convalescence of disease.Serum amyloid sample egg
White A (SAA) is a height heterogeneity albumen, represents a relative molecular mass as 12000 family.SAA in some aspects
Sensitivity is had more than other common acute albumen, such as in virus and bacterium infection, the serum-concentration of SAA increases, and in disease
In poison infection reaction, the serum-concentration of C reactive protein (CRP) hardly increases or increases unobvious.SAA can be by activation
Property inflammatory mediators and the metalloproteinases such as granulocyte and the induction of other inflammatory cells release, to which the inflammatory for enhancing body is anti-
It answers, there is immunoregulation effect.Therefore, while SAA is considered as a kind of Inflammatory Mediators, also as a kind of the tactile of inflammatory signals
Agent is sent out to exist.The content concn of SAA is the sensitive indicator for reflecting infectious diseases Earlier period of inflammation, and the auxiliary of inflammation is contributed to examine
Break, assesses its activity, monitors its activity and treatment.
It is used at present about serum amyloid A protein assay kit, be all some independent reagent bottles, the inside is held
Different reaction reagents, because its shape is as most of shapes for holding the reagent bottle of the reagents of other purposes,
Therefore it in the case where not paying special attention to label, is very easy to mix up.And the capacity of reagent bottle is mostly identical, and it is used for serum
When measuring, the adding proportion of reagent really differs the various reagents that amyloid A measures, therefore when a kind of reagent is finished
When, another reagent may also have very much, purchase neither one standard, very troublesome.
Utility model content
The purpose of this utility model is that in view of the deficiencies of the prior art, providing a kind of serum amyloid A protein measurement examination
Agent box.
To solve the above problems, the utility model provides following technical scheme：
A kind of serum amyloid A protein assay kit, including the first reagent bottle, the second reagent bottle and that are set up in parallel
Three reagent bottles are equipped with the connector that three links into an integrated entity between the first reagent bottle, the second reagent bottle and third reagent bottle, the
The capacity of one reagent bottle, the second reagent bottle and third reagent bottle successively decreases successively, the first reagent bottle, the second reagent bottle and third reagent
It is equipped with bottleneck on bottle, the bottleneck bore of the first reagent bottle, the second reagent bottle and third reagent bottle successively decreases successively, the first reagent
It is all provided on the bottleneck of bottle, the second reagent bottle and third reagent bottle and is bolted with bottle cap.
Further, the plastic injection that the first reagent bottle, the second reagent bottle, third reagent bottle and connector are integrally formed
Part.
Further, connector includes being set to the second reagent bottle and third reagent bottle bottom base, the second reagent bottle and the
Three reagent bottles are mounted on pedestal, and pedestal one end extends to the first reagent bottle direction to be connected to outside the first reagent bottle.
Further, connector further includes several horizontal connection pieces, and several horizontal connection pieces are along reagent bottle short transverse etc.
It is spaced apart, horizontal connection piece is set in outside the second reagent bottle and third reagent bottle, and horizontal connection piece one end is to the first reagent
Bottle direction, which extends, to be connected to outside the first reagent bottle.
Further, connector further includes the first vertical connection sheet and the second vertical connection sheet, the first vertical connection sheet
Two edges in left and right are connected to outside the first reagent bottle and the second reagent bottle, the edge connection of left and right two of the second vertical connection sheet
Outside the second reagent bottle and third reagent bottle, the upper edge of the first vertical connection sheet and the second vertical connection sheet is both connected to most
On the lower face of upper layer horizontal connection piece, and the first vertical connection sheet and the second vertical connection sheet run through top layer's level and connect
It is connected on the upper surface of pedestal after all horizontal connection pieces below contact pin.
Advantageous effect：A kind of serum amyloid A protein assay kit of the utility model, using the first of integrated design
Reagent bottle, the second reagent bottle and third reagent bottle, amount of capacity are successively decreased successively, and the ratio between capacity of three is according to serum amyloid sample
Albumin A measure needed for ratio of reagents design, after repeatedly measuring, the first reagent bottle, the second reagent bottle and third reagent bottle meeting
Sky falls together, therefore in buying and the preservation of reagent, record, also can be very convenient, and according to amount of capacity, devises
The bottleneck of different bores avoids once pouring out excessive.
Description of the drawings
Fig. 1 is the utility model schematic top plan view；
Fig. 2 is the utility model schematic elevation view；
Fig. 3 is the utility model dimensional structure diagram；
Reference sign：First reagent bottle 1, the second reagent bottle 2, third reagent bottle 3, connector 4, pedestal 4a are horizontal
Connection sheet 4b, the first vertical connection sheet 4c, the second vertical connection sheet 4d.
Specific implementation mode
With reference to the accompanying drawings of the specification and embodiment, specific embodiment of the utility model is described in further detail：
Referring to figs. 1 to a kind of serum amyloid A protein assay kit shown in Fig. 3, including be set up in parallel first examination
Agent bottle 1, the second reagent bottle 2 and third reagent bottle 3, being equipped between the first reagent bottle 1, the second reagent bottle 2 and third reagent bottle 3 will
The capacity of the connector 4 that three links into an integrated entity, the first reagent bottle 1, the second reagent bottle 2 and third reagent bottle 3 successively decreases successively, the
Bottleneck, the first reagent bottle 1, the second reagent bottle 2 and third are equipped on one reagent bottle 1, the second reagent bottle 2 and third reagent bottle 3
The bottleneck bore of reagent bottle 3 successively decreases successively, and spiral shell is all provided on the bottleneck of the first reagent bottle 1, the second reagent bottle 2 and third reagent bottle 3
It is connected to bottle cap.
For the utility model using the first reagent bottle 1, the second reagent bottle 2 and the third reagent bottle 3 of integrated design, capacity is big
Small to successively decrease successively, the ratio between capacity of three measures required ratio of reagents to design according to serum amyloid A protein, for example, surveying
Periodically, need to put into A, B, C three's reagent, three kinds of reagents when measuring required ratio be 5：2:1, then the first reagent bottle 1, second
The ratio between capacity of reagent bottle 2 and third reagent bottle 3 is 5：2:1, after repeatedly measuring, the first reagent bottle 1, the second reagent bottle 2 and the
Three reagent bottles 3 sky can fall together, therefore in buying and the preservation of reagent, record, also can be very convenient, and according to capacity
Size has been specifically designed the bottleneck of different bores, avoids once pouring out excessive.
The plastic injection piece that first reagent bottle 1, the second reagent bottle 2, third reagent bottle 3 and connector 4 are integrally formed, is adopted
With Shooting Technique can dispensable mould be molded special tectonic product.
Connector 4 includes being set to 3 bottom base 4a of the second reagent bottle 2 and third reagent bottle, the second reagent bottle 2 and third examination
Agent bottle 3 is mounted on pedestal 4a, and the one end pedestal 4a extends to 1 direction of the first reagent bottle to be connected to outside the first reagent bottle 1, by the
One reagent bottle 1, the second reagent bottle 2 and third reagent bottle 3 link into an integrated entity.
Connector 4 further includes several horizontal connection piece 4b, several horizontal connection piece 4b along reagent bottle short transverse at equal intervals
Distribution, horizontal connection piece 4b are set in outside the second reagent bottle 2 and third reagent bottle 3, and horizontal connection one end piece 4b is tried to first
1 direction of agent bottle, which extends, to be connected to outside the first reagent bottle 1, and the design of horizontal connection piece 4b is to make the first reagent bottle 1, second
The connection of reagent bottle 2 and third reagent bottle 3 is more firm.
Connector 4 further includes the first vertical vertical connection sheet 4d of connection sheet 4c and second, a left side of the first vertical connection sheet 4c
Right two edges are connected to outside the first reagent bottle 1 and the second reagent bottle 2, and the edge of left and right two of the second vertical connection sheet 4d connects
It is connected on outside the second reagent bottle 2 and third reagent bottle 3, the upper edge of the first vertical vertical connection sheet 4d of connection sheet 4c and second is equal
It is connected on the lower face of top layer horizontal connection piece 4b, and the first vertical vertical connection sheet 4d of connection sheet 4c and second are passed through
It is connected on the upper surface of pedestal 4a after wearing all horizontal connection piece 4b below top layer horizontal connection piece 4b.First vertically connects
The design of the vertical connection sheet 4d of contact pin 4c and second is also for making the first reagent bottle 1, the second reagent bottle 2 and third reagent bottle
3 connection is more firm.
The above descriptions are merely preferred embodiments of the present invention, not makees to the technical scope of the utility model
Go out any restrictions, thus it is any trickle amendment made by the above technical examples according to the technical essence of the present invention, equivalent
Variation and modification, in the range of still falling within the technical solution of the utility model.
Claims (5)
1. a kind of serum amyloid A protein assay kit, it is characterised in that：Including be set up in parallel the first reagent bottle (1),
Two reagent bottles (2) and third reagent bottle (3) are equipped between the first reagent bottle (1), the second reagent bottle (2) and third reagent bottle (3)
The connector (4) that three is linked into an integrated entity, the first reagent bottle (1), the second reagent bottle (2) and third reagent bottle (3) capacity
Successively decrease successively, bottleneck, the first reagent bottle are equipped on the first reagent bottle (1), the second reagent bottle (2) and third reagent bottle (3)
(1), the bottleneck bore of the second reagent bottle (2) and third reagent bottle (3) successively decreases successively, the first reagent bottle (1), the second reagent bottle
(2) it and is all provided on the bottleneck of third reagent bottle (3) and is bolted with bottle cap.
2. a kind of serum amyloid A protein assay kit according to claim 1, it is characterised in that：First reagent bottle
(1), the plastic injection piece that the second reagent bottle (2), third reagent bottle (3) and connector (4) are integrally formed.
3. a kind of serum amyloid A protein assay kit according to claim 2, it is characterised in that：Connector (4) wraps
Include the pedestal (4a) set on the second reagent bottle (2) and third reagent bottle (3) bottom, the second reagent bottle (2) and third reagent bottle (3)
It is mounted on pedestal (4a), pedestal one end (4a) extends to the first reagent bottle (1) direction is connected to the first reagent bottle (1) outside.
4. a kind of serum amyloid A protein assay kit according to claim 3, it is characterised in that：Connector (4) is also
Including several horizontal connection pieces (4b), several horizontal connection pieces (4b) are spacedly distributed along reagent bottle short transverse, horizontal connection
It is external that piece (4b) is set in the second reagent bottle (2) and third reagent bottle (3), and horizontal connection piece one end (4b) is to the first reagent bottle
(1) direction, which extends, is connected to the first reagent bottle (1) outside.
5. a kind of serum amyloid A protein assay kit according to claim 4, it is characterised in that：Connector (4) is also
Including the first vertical connection sheet (4c) and the second vertical connection sheet (4d), the edge of left and right two of the first vertical connection sheet (4c) connects
It is connected on that the first reagent bottle (1) and the second reagent bottle (2) are external, the edge of left and right two of the second vertical connection sheet (4d) is connected to the
Two reagent bottles (2) and third reagent bottle (3) are external, the upper edge of the first vertical connection sheet (4c) and the second vertical connection sheet (4d)
It is both connected on the lower face of top layer's horizontal connection piece (4b), and the first vertical connection sheet (4c) and the second vertical connection sheet
The upper end of pedestal (4a) is connected to after all horizontal connection pieces (4b) that (4d) runs through below top layer's horizontal connection piece (4b)
On face.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201721918920.7U CN207636495U (en) | 2017-12-29 | 2017-12-29 | A kind of serum amyloid A protein assay kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201721918920.7U CN207636495U (en) | 2017-12-29 | 2017-12-29 | A kind of serum amyloid A protein assay kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN207636495U true CN207636495U (en) | 2018-07-20 |
Family
ID=62851255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201721918920.7U Expired - Fee Related CN207636495U (en) | 2017-12-29 | 2017-12-29 | A kind of serum amyloid A protein assay kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN207636495U (en) |
-
2017
- 2017-12-29 CN CN201721918920.7U patent/CN207636495U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stuart et al. | Red cell deformability and haematological disorders | |
| US20100028935A1 (en) | Convex bottom microwell | |
| CN207636495U (en) | A kind of serum amyloid A protein assay kit | |
| CN201828517U (en) | Kit for detecting hand-foot-and-mouth disease by adopting biotin fluorescence method | |
| CN203745059U (en) | Electronic scale used for weighing liquid | |
| Sowemimo-Coker et al. | The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells. | |
| Renfree et al. | Developmental changes in the composition and amount of mouse fetal fluids | |
| CN205514551U (en) | Inspecting device special for animal husbandry and veterinary | |
| Nisar et al. | Nutritional status of hospitalized children with nutritional anaemia: a cross sectional study | |
| CN208621519U (en) | A kind of urine list hydrocarbon phenolic metabolism object assay kit | |
| CN201852713U (en) | Wall hanging type acquisition rack for medical test | |
| CN204330114U (en) | A kind of automatic very heavy measurement scale measured in Internet of Things | |
| CN216449440U (en) | Simple cervical warburg effect detection freeze-drying reagent | |
| CN216900566U (en) | Low protein adsorption immunodetection reaction cup | |
| CN203519135U (en) | Household electronic scale | |
| Bilginer Kartal et al. | Exploring Neuronal Differentiation Profiles in SH-SY5Y Cells through Magnetic Levitation Analysis | |
| Vannucchi et al. | Serum levels of vitamin A, E, C and B2, carotenoid and zinc in hospitalized elderly patients | |
| CN208999444U (en) | A kind of diabetes autoantibody immunity percolation joint inspection kit | |
| Dumas et al. | Flow cytometric analysis of human epidermal cell ageing using two fluorescent mitochondrial probes. | |
| CN207730778U (en) | A kind of RBP ELISA assay kit | |
| CN202033364U (en) | Combined assay kit for rheumatoid diseases | |
| CN214439185U (en) | Clinical medicine experiment graduated flask | |
| CN208547645U (en) | Portable ABO+Rh (D) blood type test card | |
| Benga et al. | Comparative nuclear magnetic resonance studies of diffusional water permeability of red blood cells from different species. XI. Horses introduced to Australia and European horses (Equus caballus) | |
| CN201307106Y (en) | Drug sensitivity test lath |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180720 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |